15
Oct
Personal data processing in the medical research sector: What's new in the italian artificial intelligence law
On October 10, 2025, the new Italian law on artificial intelligence entered into force.
15
Oct
Public procurement of medical devices in the EU: New restrictions on access for economic operators and devices from China
On 30 June 2025, European Commission Implementing Regulation (EU) 2025/1197 came into force, introducing restrictions on access to the EU market for medical devices for economic operators and medical devices originating in the People's Republic of China.
15
Oct
The European Accessibility Act as implemented in Italy: What’s new for online pharmacies?
From June 28, 2025, the accessibility requirements provided for under the European Accessibility Act have become applicable across the European Union to a host of products and services, with Italy having transposed the EAA through Legislative Decree 27 May 2022, n° 82.
15
Oct
Pharma-influencers under the scrutiny of the Italian Self-Regulatory Body
The Monitoring Committee, issued two injunctions against two companies operating in the pharma sector for advertising disseminated by two pharma-influencers – pharmaceutical professionals who use social media and other digital communication tools to share health-related content.
15
Oct
Italian Competition Authority conditionally clears a merger between two pharmaceutical distribution companies
On July 29, 2025, the Italian Competition Authority issued a decision imposing conditions to a merger between ‘La Farmacia dei Farmacisti S.p.A’ and ‘Cooperativa Esercenti Farmacia S.c.a.r.l’, resulting in the creation of QFarma Srl, Italy's largest pharmaceutical distribution group.
15
Oct
Biotech medicines and advanced therapies: Regulatory challenges in a complex sector
The biotechnology sector is currently one of the most dynamic and rapidly evolving industries worldwide, with applications spanning agriculture, industry, and medicine.
